Skip to main content

Table 2 Details of annual cost in US$ by socio-demographic and clinical characteristics of the study participants

From: Type 2 diabetes mellitus in Bangladesh: a prevalence based cost-of-illness study

Variables

Direct cost

Indirect cost

Total cost

Mean

Median (percentiles)

Mean

Median (percentiles)

Mean

Median (percentiles)

Genderb

 Male

795.2

456.1 (273.6, 893.4)

81.6

19.5 (0, 62.5)

876.9

497.9 (292.0, 977.3)

 Female

765.7

446.6 (278.8, 905.2)

84.4

52.1 (16.1, 93.7)

850.1

516.89 (332.7, 988.3)

Age (years)c

  ≤ 40

519.6

331.1 (205.4, 564.9)

68.8

41.6 (18.48, 72.91)

588.4

385.7 (241.0, 616.2)

 41–60

738.7

421.1 (270.3, 784.7)

103.0

52.1 (19.5, 104.2)

841.8

476.2 (310.1, 860.1)

 61–80

934.9

587.4 (337.1, 1168.9)

56.1

0 (0, 52.1)

991.0

613.7 (351.3, 1247.3)

  > 80

1376.9

1052.1 (682.9, 1845.5)

57.1

0 (0, 0)

1434.1

1133.1 (712.2, 1936.1)

Educationc

 Illiterate

575.3

421.1 (254.1, 705.5)

61.6

39.1 (3.6, 72.9)

636.9

437.2 (287.5, 775.3)

 Primary

759.5

513.1 (291.3, 958.0)

59.3

31.2 (0, 72.9)

818.9

536.41 (323.5, 1036.1)

 Secondary

874.1

483.1 (294.7, 989.4)

88.0

35.1 (0, 83.3)

962.1

529.2 (333.7, 1092.1)

 Tertiary

733.9

409.4 (224.6, 831.8)

104.5

41.6 (0, 91.1)

838.4

452.0 (261.2, 913.5)

Work statusc

 Unemployed

627.5

469.0 (298.7, 598.3)

48.0

0 (0, 0)

675.6

469.0 (298.7, 606.2)

 Employed

598.9

343.1 (217.8, 607)

116.0

41.6 (18.7, 87.5)

715.0

393.3 (255.3, 700.7)

 Housewives

798.9

488.3 (294.3, 936.7)

87.0

52.1 (20.8, 104.1)

885.9

533.6 (359.3, 1025.1)

 Retired

1027.0

617.4 (369, 1189.9)

34.8

0 (0, 10.9)

1061.9

644.3 (374.2, 1298.3)

Area of residencec

 Rural

359.8

291.3 (202.4, 442.2)

61.7

47.9 (11.4, 83.3)

421.6

369.0 (239.6, 522.3)

 Semi-urban

388.3

295.5 (228.1, 494.6)

48.1

33.2 (7.8, 70.3)

436.5

353.3 (253.7, 541.1)

 Urban

931.3

545.3 (324.9, 1089.6)

93.1

34.3 (0, 87.5)

1024.4

590.3 (361.4, 1205.4)

Monthly household income (US$)c

  ≤ 250

739.6

465.5 (258.1, 846.1)

65.2

31.2 (0, 78.1)

804.9

499.4 (289.5, 920.3)

 251–750

692.1

407.9 (267.6, 757.3)

64.6

41.66 (1.30, 72.9)

756.8

456.5 (305.2, 810.7)

 751 and above

986.8

571.8 (340.5, 1262.8)

138.0

41.6 (0, 125.0)

1124.9

499.4 (289.5, 920.3)

Duration of diabetes (in year)c

  ≤ 5

526.3

325.8 (220.8, 539.2)

53.7

32.6 (10.4, 67.1)

580.1

378.9 (260.2, 589.0)

 6–10

645.9

398.0 (258.3, 691.7)

61.4

41.6 (3.9, 72.9)

707.4

458.1 (292.5, 760.6)

  ≥ 11

1044.1

679.8 (378.8, 1251.3)

116.7

37.5 (0, 114.5)

1160.8

746.6 (418.3, 1442.5)

Mode of treatmentc

 OHA

476.2

291.4 (209.6, 511.2)

49.9

31.2 (4.0, 62.5)

526.17

335.0 (238.7, 534.3)

 Insulin

702.6

441.9 (224.3, 842.3)

67.2

41.6 (8.8, 83.3)

769.89

477.1 (259.8, 902.8)

 Insulin + OHA

970.9

586.0 (368.9, 1129.6)

104.2

41.6 (0, 104.1)

1075.20

642.7 (412.4, 1223.7)

Family history of diabetesb

 Yes

818.4

487.3 (287.0, 964.3)

97.1

41.6 (9.8, 93.7)

915.6

524.3 (321.7, 1100.8)

 No

762.4

441.4 (270.5, 879.9)

75.4

31.2 (0, 72.9)

837.9

493.1 (298.9, 954.2)

HbA1c (%)

 Good (≤6.9)

527.1

318.9 (205.9, 513.3)

84.5

31.2 (0, 65.1)

611.7

367.5 (234.2, 562.8)

 Fair (7–7.9)

552.1

366.6 (242.3, 637.5)

53.2

26.0 (0, 62.5)

605.4

409.9 (277.8, 665.1)

 Poor (≥8)

567.9

398.9 (267.2, 633.2)

58.5

36.4 (7.8, 72.9)

626.5

450.4 (300.7, 717.3)

Number of complicationa,c

 None

466.8

295.9 (207.3, 507.0)

56.3

31.2 (15.6, 65.1)

523.2

347.9 (237.8, 549.2)

 One or two

657.5

379.9 (261.8, 670.7)

81.9

36.4 (0, 83.3)

739.4

437.1 (293.5, 739.7)

 Three or more

1234.3

966.9 (511.1, 1519.8)

117.1

43.7 (0,130.2)

1351.5

1036.8 (547.8, 1718.5)

History of co-morbidityc

 None

595.5

354.2 (219.8, 580.7)

63.8

31.2 (10.4, 72.9)

659.3

418.2 (260.7, 632.8)

 Hypertension

870.1

533.9 (317.5, 1041.9)

94.3

41.6 (0, 91.1)

964.4

582.4 (362.7, 1150.3)

 Dyslipidaemia

566.8

332.6 (228.1, 561.9)

56.9

27.3 (9.1, 62.5)

623.7

376.1 (259.6, 608.8)

 Hypertension + dyslipidaemia

926.9

534.0 (313.7, 1041.3)

95.7

41.6 (0, 91.1)

1022.6

587.6 (365, 1143.5)

  1. OHA Oral hypoglycaemic agent, HTN Hypertension
  2. aComplications include coronary artery disease, stroke, diabetic foot, nephropathy, retinopathy and neuropathy. bMann Whitney U test and cKruskal Wallis test were done for group comparison; p-value was considered significant at p < 0.05